Revvity RVTY Diagnostics — Segment revenue
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Revvity in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The official record: Revvity’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Revvity's diagnostics — segment revenue.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Revvity's diagnostics — segment revenue?
- Revvity (RVTY) reported diagnostics — segment revenue of $349.27M in Q1 2026.
- How has Revvity's diagnostics — segment revenue changed year-over-year?
- Revvity's diagnostics — segment revenue increased by 7.7% year-over-year, from $324.37M to $349.27M.
- What is the long-term trend for Revvity's diagnostics — segment revenue?
- Over 3 years (2022 to 2025), Revvity's diagnostics — segment revenue has grown at a -11.0% compound annual growth rate (CAGR), from $2.02B to $1.42B.
- What does diagnostics — segment revenue mean?
- Total sales revenue generated specifically by the diagnostics business unit.
- How do you interpret diagnostics — segment revenue?
- Increasing revenue indicates successful market penetration or product adoption, while decreasing revenue may signal competitive pressure or market saturation.
- How does diagnostics — segment revenue compare across companies?
- Standard across life sciences and diagnostics peers as a primary indicator of segment-level top-line performance.